Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4042)
- Volume 19, 2023 (185)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 14, 2018
Assessing suicide management skills of emergency medical services providers before and after suicide intervention/prevention training with Lithuanian version of suicide intervention response inventory
Lygnugaryte-Griksiene A, Leskauskas D
Neuropsychiatric Disease and Treatment 2018, 14:3405-3412
Published Date: 13 December 2018
Activation of IL-8 and its participation in cancer in schizophrenia patients: new evidence for the autoimmune hypothesis of schizophrenia
Xu LZ, Qi X, Zhu C, Wan LH
Neuropsychiatric Disease and Treatment 2018, 14:3393-3403
Published Date: 13 December 2018
Jian-Pi-Zhi-Dong-Decoction regulates the expression of glutamate transporters to attenuate glutamate excitotoxicity and exerts anti-tics effects in Tourette syndrome model rats
Yu W, Shi X, Cui X, Niu Y, Zhang W, Bai X, Wang Q, Hu L, Wang S
Neuropsychiatric Disease and Treatment 2018, 14:3381-3392
Published Date: 17 December 2018
Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia
Yang F, Chen L, Fang X, Zheng K, Zhu C, Xu C, Zhang C, Tang W
Neuropsychiatric Disease and Treatment 2018, 14:3373-3379
Published Date: 13 December 2018
Sensory function in cluster headache: an observational study comparing the symptomatic and asymptomatic sides
Malo-Urriés M, Hidalgo-García C, Estébanez-de-Miguel E, Tricás-Moreno JM, Santos-Lasaosa S, Jahanshahi M
Neuropsychiatric Disease and Treatment 2018, 14:3363-3371
Published Date: 10 December 2018
Effectiveness of parent training in improving stress-coping capability, anxiety, and depression in mothers raising children with autism spectrum disorder
Iida N, Wada Y, Yamashita T, Aoyama M, Hirai K, Narumoto J
Neuropsychiatric Disease and Treatment 2018, 14:3355-3362
Published Date: 7 December 2018
Social function of adult men with attention-deficit/hyperactivity disorder in the context of military service
Noh GM, Lee SM, Bahn GH
Neuropsychiatric Disease and Treatment 2018, 14:3349-3354
Published Date: 7 December 2018
Cognitive dysfunction and negative symptoms in patients with schizophrenia and their first-degree relatives from simplex and multiplex families
Zhang Z, Zhang R, Qin P, Tan L
Neuropsychiatric Disease and Treatment 2018, 14:3339-3348
Published Date: 5 December 2018
Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder
Huang YC, Shi X, Li ZY, Shen Y, Shi XX, Wang LY, Li GF, Yuan Y, Wang JX, Zhang YC, Zhao L, Zhang M, Kang Y, Liang Y
Neuropsychiatric Disease and Treatment 2018, 14:3329-3337
Published Date: 3 December 2018
Altered functional connectivity of primary visual cortex in late blindness
Wen Z, Zhou FQ, Huang X, Dan HD, Xie BJ, Shen Y
Neuropsychiatric Disease and Treatment 2018, 14:3317-3327
Published Date: 3 December 2018
Regional differences in the risk of insomnia symptoms among patients from general hospital outpatient clinics
Zheng W, Luo XN, Li HY, Ke XY, Dai Q, Zhang CJ, Zhang XY, Ning YP
Neuropsychiatric Disease and Treatment 2018, 14:3307-3315
Published Date: 30 November 2018
Effects of personality on the association between paroxetine plasma concentration and response
Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Nakamura K
Neuropsychiatric Disease and Treatment 2018, 14:3299-3306
Published Date: 29 November 2018
Developmental lead (Pb)-induced deficits in hippocampal protein translation at the synapses are ameliorated by ascorbate supplementation
Ahmad F, Salahuddin M, Alsamman K, AlMulla AA, Salama KF
Neuropsychiatric Disease and Treatment 2018, 14:3289-3298
Published Date: 29 November 2018
Influence of trait anxiety, child maltreatment, and adulthood life events on depressive symptoms
Uchida Y, Takahashi T, Katayama S, Masuya J, Ichiki M, Tanabe H, Kusumi I, Inoue T
Neuropsychiatric Disease and Treatment 2018, 14:3279-3287
Published Date: 27 November 2018
Children screening positive for language delay at 2.5 years: language disorder and developmental profiles
Schachinger-Lorentzon U, Kadesjö B, Gillberg C, Miniscalco C
Neuropsychiatric Disease and Treatment 2018, 14:3267-3277
Published Date: 28 November 2018
Association of HLA alleles with autism
Sayad A, Akbari MT, Noroozi R, Omrani MD, Inoko H, Taheri M, Ghafouri-Fard S
Neuropsychiatric Disease and Treatment 2018, 14:3259-3265
Published Date: 27 November 2018
Dissociative states in borderline personality disorder and their relationships to psychotropic medication
Pec O, Bob P, Simek J, Raboch J
Neuropsychiatric Disease and Treatment 2018, 14:3253-3257
Published Date: 23 November 2018
The association between depression, anxiety and substance use among Canadian post-secondary students
Esmaeelzadeh S, Moraros J, Thorpe L, Bird Y
Neuropsychiatric Disease and Treatment 2018, 14:3241-3251
Published Date: 23 November 2018
Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder
Cao P, Xing J, Cao Y, Cheng Q, Sun X, Kang Q, Dai L, Zhou X, Song Z
Neuropsychiatric Disease and Treatment 2018, 14:3231-3240
Published Date: 26 November 2018
Aberrantly expressed long noncoding RNAs and genes in Parkinson's disease
Zhou Y, Gu C, Li J, Zhu L, Huang G, Dai J, Huang H
Neuropsychiatric Disease and Treatment 2018, 14:3219-3229
Published Date: 22 November 2018
Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial
Zuilhof Z, Norris S, Blondeau C, Tessier P, Blier P
Neuropsychiatric Disease and Treatment 2018, 14:3209-3218
Published Date: 22 November 2018
Brain structural networks and connectomes: the brain–obesity interface and its impact on mental health
Chen VCH, Liu YC, Chao SH, McIntyre RS, Cha DS, Lee Y, Weng JC
Neuropsychiatric Disease and Treatment 2018, 14:3199-3208
Published Date: 26 November 2018
The hospital anxiety and depression scale, in patients with multiple sclerosis
Pais-Ribeiro JL, Martins da Silva A, Vilhena E, Moreira I, Santos E, Mendonça D
Neuropsychiatric Disease and Treatment 2018, 14:3193-3197
Published Date: 22 November 2018
The subjective perception of past, present, and future time in patients with Alzheimer's disease: a qualitative study
Shiromaru-Sugimoto A, Murakami H, Futamura A, Honma M, Kuroda T, Kawamura M, Ono K
Neuropsychiatric Disease and Treatment 2018, 14:3185-3192
Published Date: 22 November 2018
Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study
Takeshima M, Ishikawa H, Kanbayashi T, Shimizu T
Neuropsychiatric Disease and Treatment 2018, 14:3179-3184
Published Date: 22 November 2018
The comparison of violence, and the relationship with childhood trauma in Turkish men with alcohol, opiate, and synthetic cannabinoid use disorder
Ergelen M, Yalçın M, Bilici R
Neuropsychiatric Disease and Treatment 2018, 14:3169-3178
Published Date: 23 November 2018
Elevated circulating magnesium levels in patients with Parkinson’s disease: a meta-analysis
Jin X, Liu MY, Zhang DF, Gao H, Wei MJ
Neuropsychiatric Disease and Treatment 2018, 14:3159-3168
Published Date: 19 November 2018
Exploring assistive technology as a potential beneficial intervention tool for people with Alzheimer’s disease – a systematic review
Klimova B, Valis M, Kuca K
Neuropsychiatric Disease and Treatment 2018, 14:3151-3158
Published Date: 16 November 2018
Aberrant prefrontal–parietal–cerebellar circuits in alcohol dependence
Liu R, Liu BX, Ma M, Kong D, Li G, Yang J, Wu X, Zheng J, Dong Y
Neuropsychiatric Disease and Treatment 2018, 14:3143-3150
Published Date: 16 November 2018
Abnormal functional connectivity of the amygdala is associated with depressive symptoms in patients with multiple system atrophy
Zhao B, Liu H, Li H, Shang X
Neuropsychiatric Disease and Treatment 2018, 14:3133-3142
Published Date: 15 November 2018
Activation of ERK/CREB/BDNF pathway involved in abnormal behavior of neonatally Borna virus-infected rats
Li C, Xu X, Zhang X, Cheng K, Guo Y, Jie J, Guo H, He Y, Zhou C, Gui S, Zhong X, Wang H, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:3121-3132
Published Date: 15 November 2018
RIP1 and RIP3 mediate hemin-induced cell death in HT22 hippocampal neuronal cells
Su X, Wang H, Lin Y, Chen F
Neuropsychiatric Disease and Treatment 2018, 14:3111-3119
Published Date: 15 November 2018
Vitamin D3 as adjunctive therapy in the treatment of depression in tuberculosis patients: a short-term pilot randomized double-blind controlled study
Zhang L, Wang S, Zhu Y, Yang T
Neuropsychiatric Disease and Treatment 2018, 14:3103-3109
Published Date: 14 November 2018
Efficacy of light therapy on nonseasonal depression among elderly adults: a systematic review and meta-analysis
Chang CH, Liu CY, Chen SJ, Tsai HC
Neuropsychiatric Disease and Treatment 2018, 14:3091-3102
Published Date: 14 November 2018
Abnormal prefrontal brain activation during a verbal fluency task in bipolar disorder patients with psychotic symptoms using multichannel NIRS
Sun JJ, Liu XM, Shen CY, Feng K, Liu PZ
Neuropsychiatric Disease and Treatment 2018, 14:3081-3090
Published Date: 13 November 2018
Prevalence of poststroke depression in Iranian patients: a systematic review and meta-analysis
Dalvand S, Ghanei Gheshlagh R, Kurdi A
Neuropsychiatric Disease and Treatment 2018, 14:3073-3080
Published Date: 13 November 2018
Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis
Maneeton N, Maneeton B, Putthisri S, Suttajit S, Likhitsathian S, Srisurapanont M
Neuropsychiatric Disease and Treatment 2018, 14:3063-3072
Published Date: 12 November 2018
Economic analysis of acupuncture for migraine prophylaxis
Pokladnikova J, Maresova P, Dolejs J, Park AL, Wang B, Guan X, Musil F
Neuropsychiatric Disease and Treatment 2018, 14:3053-3061
Published Date: 12 November 2018
The Chinese herbal formula Fuzheng Quxie Decoction attenuates cognitive impairment and protects cerebrovascular function in SAMP8 mice
Wang F, Feng J, Yang Y, Liu J, Liu M, Wang Z, Pei H, Wei Y, Li H
Neuropsychiatric Disease and Treatment 2018, 14:3037-3051
Published Date: 9 November 2018
Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
Kulaksizoğlu B, Kara H, Bodur B, Kuloğlu M
Neuropsychiatric Disease and Treatment 2018, 14:3033-3035
Published Date: 9 November 2018
Cognitive functioning in patients treated with electroconvulsive therapy
Kalisova L, Kubinova M, Michalec J, Albrecht J, Madlova K, Raboch J
Neuropsychiatric Disease and Treatment 2018, 14:3025-3031
Published Date: 8 November 2018
Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer's disease
Giau VV, Senanarong V, Bagyinszky E, Limwongse C, An SSA, Kim SY
Neuropsychiatric Disease and Treatment 2018, 14:3015-3023
Published Date: 8 November 2018
A prescription for “nature” – the potential of using virtual nature in therapeutics
White MP, Yeo NL, Vassiljev P, Lundstedt R, Wallergård M, Albin M, Lõhmus M
Neuropsychiatric Disease and Treatment 2018, 14:3001-3013
Published Date: 8 November 2018
Biomarkers in traumatic brain injury (TBI): a review
Dadas A, Washington J, Diaz-Arrastia R, Janigro D
Neuropsychiatric Disease and Treatment 2018, 14:2989-3000
Published Date: 8 November 2018
Association study between COMT, DRD2, and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophrenia
Escamilla R, Camarena B, Saracco-Alvarez R, Fresán A, Hernández S, Aguilar-García A
Neuropsychiatric Disease and Treatment 2018, 14:2981-2987
Published Date: 5 November 2018
Parents’ impaired emotion recognition abilities are related to children’s autistic symptoms in autism spectrum disorder
Hu X, Yin L, Situ M, Guo K, Yang P, Zhang M, Huang Y
Neuropsychiatric Disease and Treatment 2018, 14:2973-2980
Published Date: 5 November 2018
Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo
Wan TJ, Yu YC, Zhao XG, Tang P, Gong YS
Neuropsychiatric Disease and Treatment 2018, 14:2965-2971
Published Date: 5 November 2018
Profile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date
Patel AB, Jimenez-Shahed J
Neuropsychiatric Disease and Treatment 2018, 14:2955-2964
Published Date: 2 November 2018
Low levels of serum magnesium are associated with poststroke cognitive impairment in ischemic stroke patients
Tu X, Qiu H, Lin S, He W, Huang G, Zhang X, Wu Y, He J
Neuropsychiatric Disease and Treatment 2018, 14:2947-2954
Published Date: 2 November 2018
Detection of cognitive impairment using a machine-learning algorithm
Youn YC, Choi SH, Shin HW, Kim KW, Jang JW, Jung JJ, Hsiung GY, Kim SY
Neuropsychiatric Disease and Treatment 2018, 14:2939-2945
Published Date: 1 November 2018
Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report
Kitaguchi N, Kato T, Matsunaga S, Hirano K, Iwata K, Kawaguchi K, Fujita K, Takechi H, Hasegawa M, Yuzawa Y, Ito K
Neuropsychiatric Disease and Treatment 2018, 14:2931-2937
Published Date: 1 November 2018
Structural equation modeling analysis of social support, coping strategies, depression and suicidal ideation among people living with HIV/AIDS in Changsha, China
Tang X, Wang HY, Wang M, Ren XH, Jiang FR, Li JL
Neuropsychiatric Disease and Treatment 2018, 14:2923-2930
Published Date: 31 October 2018
Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials
Kishi T, Matsunaga S, Iwata N
Neuropsychiatric Disease and Treatment 2018, 14:2915-2922
Published Date: 30 October 2018
Neurofeedback versus psychostimulants in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a systematic review
Razoki B
Neuropsychiatric Disease and Treatment 2018, 14:2905-2913
Published Date: 30 October 2018
Structural and functional brain abnormalities in drug-naive, first-episode, and chronic patients with schizophrenia: a multimodal MRI study
Wu F, Zhang Y, Yang Y, Lu X, Fang Z, Huang J, Kong L, Chen J, Ning Y, Li X, Wu K
Neuropsychiatric Disease and Treatment 2018, 14:2889-2904
Published Date: 30 October 2018
Short duration of focal onset awareness and impaired awareness seizure are characteristic features of epilepsy in elderly patients
Fujimoto A, Okanishi T, Masuda Y, Sato K, Nishimura M, Baba S, Itamura S, Homma Y, Enoki H
Neuropsychiatric Disease and Treatment 2018, 14:2879-2887
Published Date: 30 October 2018
Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder
Lam RW, Lamy FX, Danchenko N, Yarlas A, White MK, Rive B, Saragoussi D
Neuropsychiatric Disease and Treatment 2018, 14:2861-2877
Published Date: 29 October 2018
Predictors of sleep disturbance in heroin users receiving methadone maintenance therapy: a naturalistic study in Taiwan
Li DJ, Chung KS, Wu HC, Hsu CY, Yen CF
Neuropsychiatric Disease and Treatment 2018, 14:2853-2859
Published Date: 26 October 2018
Sexual dysfunction in cervical dystonia and blepharospasm
Marek M, Grobe-Einsler M, Bedarf JR, Wabbels B, Paus S
Neuropsychiatric Disease and Treatment 2018, 14:2847-2852
Published Date: 26 October 2018
Neuroprogression: the hidden mechanism of depression
Labra Ruiz NA, Santamaría del Ángel D, Juárez Olguín H, Lindoro Silva M
Neuropsychiatric Disease and Treatment 2018, 14:2837-2845
Published Date: 30 October 2018
Neuromodulation in eating disorders and obesity: a promising way of treatment?
Jáuregui-Lobera I, Martínez-Quiñones JV
Neuropsychiatric Disease and Treatment 2018, 14:2817-2835
Published Date: 26 October 2018
Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate
Mathe}ws M, Nuamah I, Savitz AJ, Hough DW, Najarian D, Kim E, Gopal S
Neuropsychiatric Disease and Treatment 2018, 14:2807-2816
Published Date: 25 October 2018
Violence in persons with and without psychosis in the Czech Republic: risk and protective factors
Černý M, Hodgins S, Kučíková R, Kážmér L, Lambertová A, Nawka A, Nawková L, Parzelka A, Raboch J, Bob P, Vevera J
Neuropsychiatric Disease and Treatment 2018, 14:2793-2805
Published Date: 23 October 2018
Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
Chou WJ, Wang LJ, Lin CH, Liang SY, Chen VCH, Hou YM, Huang RR, Chou MC, Shang CY, Ho CP, Lai MC
Neuropsychiatric Disease and Treatment 2018, 14:2783-2791
Published Date: 23 October 2018
microRNA-451 protects neurons against ischemia/reperfusion injury-induced cell death by targeting CELF2
Liu Q, Hu Y, Zhang M, Yan Y, Yu H, Ge L
Neuropsychiatric Disease and Treatment 2018, 14:2773-2782
Published Date: 23 October 2018
Abnormal intrinsic brain activities in stable patients with COPD: a resting-state functional MRI study
Wang W, Li H, Peng D, Luo J, Xin H, Yu H, Yu J
Neuropsychiatric Disease and Treatment 2018, 14:2763-2772
Published Date: 17 October 2018
Depression, anxiety, and stress and their association with khat use: a cross-sectional study among Jazan University students, Saudi Arabia
Al Bahhawi T, Albasheer OB, Makeen AM, Arishi AM, Hakami OM, Maashi SM, Al-Khairat HK, Alganmy OM, Sahal YA, Sharif AA, Mahfouz MS
Neuropsychiatric Disease and Treatment 2018, 14:2755-2761
Published Date: 17 October 2018
Lithium treatment in bipolar adolescents: a follow-up naturalistic study
Masi G, Milone A, Scrinzi G, Mucci M, Viglione V, Bruni G, Berloffa S, Pisano S
Neuropsychiatric Disease and Treatment 2018, 14:2749-2753
Published Date: 17 October 2018
Are 24-hour motor activity patterns associated with continued rapid response to ketamine?
Duncan Jr WC, Slonena EE, Hejazi NS, Brutsche N, Park LT, Henter ID, Ballard ED, Zarate Jr CA
Neuropsychiatric Disease and Treatment 2018, 14:2739-2748
Published Date: 16 October 2018
Neuronal connectivity in major depressive disorder: a systematic review
Helm K, Viol K, Weiger TM, Tass PA, Grefkes C, del Monte D, Schiepek G
Neuropsychiatric Disease and Treatment 2018, 14:2715-2737
Published Date: 17 October 2018
The correlation between longitudinal changes in hypothalamic–pituitary–adrenal (HPA)-axis activity and changes in neurocognitive function in mixed-state bipolar II disorder
Lee HH, Chang CH, Wang LJ, Wu CC, Chen HL, Lu T, Lu RB, Lee SY
Neuropsychiatric Disease and Treatment 2018, 14:2703-2713
Published Date: 15 October 2018
Minocycline as adjunct therapy for a male patient with deficit schizophrenia
Chen X, Xiong Z, Li Z, Yang Y, Zheng Z, Li Y, Xie Y, Li Z
Neuropsychiatric Disease and Treatment 2018, 14:2697-2701
Published Date: 12 October 2018
The effect of different frequencies of electroacupuncture on BDNF and NGF expression in the hippocampal CA3 area of the ischemic hemisphere in cerebral ischemic rats
Duan X, Zhang L, Yu J, Wei W, Liu X, Xu F, Guo S
Neuropsychiatric Disease and Treatment 2018, 14:2689-2696
Published Date: 11 October 2018
Positive metacognitions about alcohol mediate the relationship between FKBP5 variability and problematic drinking in a sample of young women
Dragan WŁ, Domozych W, Czerski PM, Dragan M
Neuropsychiatric Disease and Treatment 2018, 14:2681-2688
Published Date: 11 October 2018
Neuronavigation-guided high-dose repetitive transcranial magnetic stimulation for the treatment of depressive adolescents with suicidal ideation: a case series
Pan F, Li D, Wang X, Lu S, Xu Y, Huang M
Neuropsychiatric Disease and Treatment 2018, 14:2675-2679
Published Date: 10 October 2018
Effects of cognitive behavioral therapy for depression on improving insomnia and quality of life in Chinese women with breast cancer: results of a randomized, controlled, multicenter trial
Qiu H, Ren W, Yang Y, Zhu X, Mao G, Mao S, Lin Y, Shen S, Li C, Shi H, Jiang S, He J, Zhao K, Fu Y, Hu X, Gu Y, Wang K, Guo X, He J
Neuropsychiatric Disease and Treatment 2018, 14:2665-2673
Published Date: 10 October 2018
Menstrual disorders and their determinants among women with epilepsy
Bosak M, Słowik A, Turaj W
Neuropsychiatric Disease and Treatment 2018, 14:2657-2664
Published Date: 10 October 2018
Neuropsychiatric disturbances in atypical parkinsonian disorders
Belvisi D, Berardelli I, Suppa A, Fabbrini A, Pasquini M, Pompili M, Fabbrini G
Neuropsychiatric Disease and Treatment 2018, 14:2643-2656
Published Date: 9 October 2018
Enduring effects of a five-week behavioral activation program for subthreshold depression among late adolescents: an exploratory randomized controlled trial
Takagaki K, Okamoto Y, Jinnin R, Mori A, Nishiyama Y, Yamamura T, Yokoyama S, Shiota S, Okamoto Y, Miyake Y, Ogata A, Kunisato Y, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S
Neuropsychiatric Disease and Treatment 2018, 14:2633-2641
Published Date: 9 October 2018
Inefficient understanding of non-factive mental verbs with social aspect in adults: comparison to cognitive factive verb processing
Nazlidou E, Moraitou D, Natsopoulos D, Papaliagkas V, Masoura E, Papantoniou G
Neuropsychiatric Disease and Treatment 2018, 14:2617-2631
Published Date: 10 October 2018
Characteristics of brain functional and structural connectivity in alexithymic students
Fang Y, Li M, Mei M, Sun X, Han D
Neuropsychiatric Disease and Treatment 2018, 14:2609-2615
Published Date: 9 October 2018
Internalized stigma and its correlates among patients with severe mental illness
Szcześniak D, Kobyłko A, Wojciechowska I, Kłapciński M, Rymaszewska J
Neuropsychiatric Disease and Treatment 2018, 14:2599-2608
Published Date: 8 October 2018
Postseizure aphasia in Wernicke's encephalopathy: a case report and review of literature
Devaraj S, Muralles SA, Gill CE, Meresh E
Neuropsychiatric Disease and Treatment 2018, 14:2593-2598
Published Date: 8 October 2018
Upregulation of vitamin D-related genes in schizophrenic patients
Asadzadeh Manjili F, Kalantar SM, Arsang-Jang S, Ghafouri-Fard S, Taheri M, Sayad A
Neuropsychiatric Disease and Treatment 2018, 14:2583-2591
Published Date: 9 October 2018
Posterior pituitary neurohormonal disturbances in schizophrenia and role of oxytocin in treatment – need for more short- and long-term studies
Gul O, Gul S, Godil AA
Neuropsychiatric Disease and Treatment 2018, 14:2579-2582
Published Date: 5 October 2018
Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
Citrome L
Neuropsychiatric Disease and Treatment 2018, 14:2563-2577
Published Date: 5 October 2018
Clinical and neuropsychological outcomes for children with phenylketonuria in Upper Egypt; a single-center study over 5 years
Sadek AA, Hassan MH, Mohammed NA
Neuropsychiatric Disease and Treatment 2018, 14:2551-2561
Published Date: 5 October 2018
Remitting long-standing major depression in a multiple sclerosis patient with several concurrent conditions
Sachinvala ND, Stergiou A, Haines DE
Neuropsychiatric Disease and Treatment 2018, 14:2545-2550
Published Date: 4 October 2018
Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia
Takada R, Yamamuro K, Kishimoto T
Neuropsychiatric Disease and Treatment 2018, 14:2541-2544
Published Date: 2 October 2018
Spatial disorientation and executive dysfunction in elderly nondemented patients with Parkinson’s disease
Cammisuli DM, Crowe S
Neuropsychiatric Disease and Treatment 2018, 14:2531-2539
Published Date: 2 October 2018
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N
Neuropsychiatric Disease and Treatment 2018, 14:2519-2530
Published Date: 1 October 2018
Association between reduced quality of life and depression in patients with type 2 diabetes mellitus: a cohort study in a Mexican population
Juárez-Rojop IE, Fortuny-Falconi CM, González-Castro TB, Tovilla-Zárate CA, Villar-Soto M, Rodríguez Sanchez E, Hernández-Díaz Y, López-Narvaez ML, Ble-Castillo JL, Pérez-Hernández N, Rodríguez-Pérez JM
Neuropsychiatric Disease and Treatment 2018, 14:2511-2518
Published Date: 4 October 2018
Construct validity and reliability of the Tachikawa Resilience Scale in the Japan Ground Self-Defense Force personnel
Saito T, Nagamine M, Shigemura J, Tanichi M, Toda H, Shimizu K, Yoshino A
Neuropsychiatric Disease and Treatment 2018, 14:2505-2510
Published Date: 2 October 2018
HPA-axis genes as potential risk variants for neurocognitive decline in trauma-exposed, HIV-positive females
Jacobs S, Moxley K, Womersley JS, Spies G, Hemmings SMJ, Seedat S
Neuropsychiatric Disease and Treatment 2018, 14:2497-2504
Published Date: 28 September 2018
The role of COMT gene Val108/158Met polymorphism in suicidal behavior: systematic review and updated meta-analysis
González-Castro TB, Hernández-Díaz Y, Juárez-Rojop IE, López-Narváez ML, Tovilla-Zárate CA, Ramirez-Bello J, Pérez-Hernández N, Genis-Mendoza AD, Fresan A, Guzmán-Priego CG
Neuropsychiatric Disease and Treatment 2018, 14:2485-2496
Published Date: 28 September 2018
Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
Huang J, Wang Y, Chen J, Zhang Y, Yuan Z, Yue L, Haro JM, Moneta MV, Novick D, Fang YR
Neuropsychiatric Disease and Treatment 2018, 14:2473-2484
Published Date: 26 September 2018
Modulatory interactions of resting-state brain functional connectivity in major depressive disorder
Tu Z, Jia YY, Wang T, Qu H, Pan JX, Jie J, Xu XY, Wang HY, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:2461-2472
Published Date: 28 September 2018
Subjective memory complaint as a useful tool for the early detection of Alzheimer’s disease
Choe YM, Byun MS, Lee JH, Sohn BK, Lee DY, Kim JW
Neuropsychiatric Disease and Treatment 2018, 14:2451-2460
Published Date: 24 September 2018
Automatic epilepsy detection using fractal dimensions segmentation and GP–SVM classification
Jirka J, Prauzek M, Krejcar O, Kuca K
Neuropsychiatric Disease and Treatment 2018, 14:2439-2449
Published Date: 21 September 2018
CBT-I and HT-I group therapy for adults with insomnia in comparison to those with insomnia and comorbid depression – a pilot study
Schlarb AA, Faber J, Hautzinger M
Neuropsychiatric Disease and Treatment 2018, 14:2429-2438
Published Date: 21 September 2018
Speech and language profiles in 4- to 6-year-old children with early diagnosis of autism spectrum disorder without intellectual disability
Kjellmer L, Fernell E, Gillberg C, Norrelgen F
Neuropsychiatric Disease and Treatment 2018, 14:2415-2427
Published Date: 20 September 2018
The microglial activation profile and associated factors after experimental spinal cord injury in rats
Zhou Y, Li N, Zhu L, Lin Y, Cheng H
Neuropsychiatric Disease and Treatment 2018, 14:2401-2413
Published Date: 20 September 2018
Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life
Chen CY, Wu CC, Huang YC, Hung CF, Wang LJ
Neuropsychiatric Disease and Treatment 2018, 14:2389-2399
Published Date: 19 September 2018
Low hedonic tone and attention-deficit hyperactivity disorder: risk factors for treatment resistance in depressed adults
Sternat T, Fotinos K, Fine A, Epstein I, Katzman MA
Neuropsychiatric Disease and Treatment 2018, 14:2379-2387
Published Date: 17 September 2018
PTSD patients show increasing cytokine levels during treatment despite reduced psychological distress
Toft H, Bramness JG, Lien L, Abebe DS, Wampold BE, Tilden T, Hestad KA, Neupane SP
Neuropsychiatric Disease and Treatment 2018, 14:2367-2378
Published Date: 17 September 2018
Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients
Suda A, Hattori S, Kishida I, Miyauchi M, Shiraishi Y, Fujibayashi M, Tsujita N, Ishii C, Ishii N, Moritani T, Hirayasu Y
Neuropsychiatric Disease and Treatment 2018, 14:2361-2366
Published Date: 17 September 2018
Altered spontaneous brain activity patterns in strabismus with amblyopia patients using amplitude of low-frequency fluctuation: a resting-state fMRI study
Min YL, Su T, Shu YQ, Liu WF, Chen LL, Shi WQ, Jiang N, Zhu PW, Yuan Q, Xu XW, Ye L, Shao Y
Neuropsychiatric Disease and Treatment 2018, 14:2351-2359
Published Date: 17 September 2018
Use of technology for care coordination initiatives for patients with mental health issues: a systematic literature review
Falconer E, Kho D, Docherty JP
Neuropsychiatric Disease and Treatment 2018, 14:2337-2349
Published Date: 13 September 2018
Discrepancies between self- and observer-rated depression severities in patients with major depressive disorder associated with frequent emotion-oriented coping responses and hopelessness
Tsujimoto E, Tsujii N, Mikawa W, Ono H, Shirakawa O
Neuropsychiatric Disease and Treatment 2018, 14:2331-2336
Published Date: 12 September 2018
Response to the paper titled "Identification of a novel CACNA1A mutation in a Chinese family with autosomal recessive progressive myoclonic epilepsy"
Graves TD
Neuropsychiatric Disease and Treatment 2018, 14:2329-2330
Published Date: 11 September 2018
Investigation of ischemic and demyelinating lesions by cerebral vasoreactivity based on transcranial Doppler sonography: a comparative study
Zoghi A, Petramfar P, Nikseresht A, Sakhaee E
Neuropsychiatric Disease and Treatment 2018, 14:2323-2328
Published Date: 11 September 2018
A randomized controlled trial of mindfulness-based Tai Chi Chuan for subthreshold depression adolescents
Zhang JY, Qin SD, Zhou YQ, Meng LN, Su H, Zhao S
Neuropsychiatric Disease and Treatment 2018, 14:2313-2321
Published Date: 10 September 2018
Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients
Roulot M, Minelli A, Bortolomasi M, Maffioletti E, Gennarelli M, Borsotto M, Heurteaux C, Mazella J
Neuropsychiatric Disease and Treatment 2018, 14:2307-2312
Published Date: 6 September 2018
Children with autism spectrum disorders and selective mutism [Corrigendum]
Steffenburg H, Steffenburg S, Gillberg C, Billstedt E
Neuropsychiatric Disease and Treatment 2018, 14:2305-2306
Published Date: 6 September 2018
Prescreening clinical trial volunteers using an online personality questionnaire
Patrick F, Young AH, Williams SCR, Perkins AM
Neuropsychiatric Disease and Treatment 2018, 14:2297-2303
Published Date: 5 September 2018
Trajectories of callous–unemotional traits from childhood to adolescence in referred youth with a disruptive behavior disorder who received intensive multimodal therapy in childhood
Masi G, Pisano S, Brovedani P, Maccaferri G, Manfredi A, Milone A, Nocentini A, Polidori L, Ruglioni L, Muratori P
Neuropsychiatric Disease and Treatment 2018, 14:2287-2296
Published Date: 5 September 2018
Do eyes with and without optic neuritis in multiple sclerosis age equally?
Lizrova Preiningerova J, Grishko A, Sobisek L, Andelova M, Benova B, Kucerova K, Havrdova EK
Neuropsychiatric Disease and Treatment 2018, 14:2281-2285
Published Date: 5 September 2018
Victimization and posttraumatic stress disorder in homeless women with mental illness are associated with depression, suicide, and quality of life
Tinland A, Boyer L, Loubière S, Greacen T, Girard V, Boucekine M, Fond G, Auquier P
Neuropsychiatric Disease and Treatment 2018, 14:2269-2279
Published Date: 4 September 2018
Vulnerability or resilience of motopsin knockout mice to maternal separation stress depending on adulthood behaviors
Hidaka C, Kashio T, Uchigaki D, Mitsui S
Neuropsychiatric Disease and Treatment 2018, 14:2255-2268
Published Date: 4 September 2018
Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study
Cai L, Huang J
Neuropsychiatric Disease and Treatment 2018, 14:2241-2254
Published Date: 3 September 2018
Association between platelet distribution width and poor outcome of acute ischemic stroke after intravenous thrombolysis
Gao F, Chen C, Lyu J, Zheng J, Ma XC, Yuan XY, Huo K, Han JF
Neuropsychiatric Disease and Treatment 2018, 14:2233-2239
Published Date: 3 September 2018
Platelet membrane receptor P2Y12 H1/H2 polymorphisms is highly associated with cerebral infarction: a case-control study
Lu SJ, Zhou XS, Zheng Q, Chen HL, Geng YL
Neuropsychiatric Disease and Treatment 2018, 14:2225-2231
Published Date: 30 August 2018
Relationship between social and cognitive functions in people with schizophrenia
Tominaga T, Tomotake M, Takeda T, Ueoka Y, Tanaka T, Watanabe SY, Kameoka N, Nakataki M, Numata S, Izaki Y, Sumitani S, Kubo H, Kaneda Y, Ohmori T
Neuropsychiatric Disease and Treatment 2018, 14:2215-2224
Published Date: 30 August 2018
Investigation of alexithymia and levels of anxiety and depression among patients with restless legs syndrome
Yılmaz O, Şengül Y, Şengül HS, Parlakkaya FB, Öztürk A
Neuropsychiatric Disease and Treatment 2018, 14:2207-2214
Published Date: 29 August 2018
Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway
Xiao Y, Zhou L, Tu Y, Li Y, Liang Y, Zhang X, Lv J, Zhong Y, Xie Y
Neuropsychiatric Disease and Treatment 2018, 14:2191-2206
Published Date: 28 August 2018
Reliability and validity of the Chinese version of Questionnaire – Children with Difficulties for Chinese children or adolescents with attention-deficit/hyperactivity disorder: a cross-sectional survey
Zheng Y, Du YS, Su LY, Zhang Y, Yuan Z, Chen Y, Liu QQ, Ke XY
Neuropsychiatric Disease and Treatment 2018, 14:2181-2190
Published Date: 27 August 2018
Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
Zhi P, Wang Y, Quan W, Su Y, Zhang H
Neuropsychiatric Disease and Treatment 2018, 14:2175-2179
Published Date: 27 August 2018
EEG correlates of induced anxiety in obsessive–compulsive patients: comparison of autobiographical and general anxiety scenarios
Kamaradova D, Brunovsky M, Prasko J, Horacek J, Hajda M, Grambal A, Latalova K
Neuropsychiatric Disease and Treatment 2018, 14:2165-2174
Published Date: 27 August 2018
Effects of behavioral activation program without psychotropic medication treatment for depression in late adolescence: case report
Takagaki K, Okamoto Y, Jinnin R, Yokoyama S, Yoshino A, Kagawa F, Okamoto Y, Miyake Y, Yamawaki S
Neuropsychiatric Disease and Treatment 2018, 14:2159-2164
Published Date: 27 August 2018
The relationship of individual social activity and cognitive function of community Chinese elderly: a cross-sectional study
Su X, Huang X, Jin Y, Wan S, Han Z
Neuropsychiatric Disease and Treatment 2018, 14:2149-2157
Published Date: 24 August 2018
ESSENCE-Q: Slavic language versions for developmental screening in young children
Stevanovic D, Knez R, Zorcec T, Anderluh M, Kodrič J, Petrov P, Hadžagić Ćatibušić F, Deljković A, Brkic Cvetkovic S, Vrljičak Davidovic N, Kuzmanić Šamija R, Đorić A, Gillberg C
Neuropsychiatric Disease and Treatment 2018, 14:2141-2148
Published Date: 23 August 2018
Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer’s disease
Huang L, Chen KL, Lin BY, Tang L, Zhao QH, Lv YR, Guo QH
Neuropsychiatric Disease and Treatment 2018, 14:2133-2140
Published Date: 21 August 2018
Construction of an Arabic computerized battery for cognitive rehabilitation of children with specific learning disabilities
Farghaly WMA, Ahmed MA, El-Tallawy HN, Elmestikawy TAH, Badry R, Farghaly MS, Omar MS, Hussein ASR, Salamah M, Mohammed AT
Neuropsychiatric Disease and Treatment 2018, 14:2123-2131
Published Date: 21 August 2018
Investigation of chromosome Y loss in men with schizophrenia
Hirata T, Hishimoto A, Otsuka I, Okazaki S, Boku S, Kimura A, Horai T, Sora I
Neuropsychiatric Disease and Treatment 2018, 14:2115-2122
Published Date: 20 August 2018
The interactive effects of ketamine and ethanol on dopamine expression in the ventral tegmental area of rats
Zhang ZB, Xu TY, You DY, Yi S, Liu Q, Li HJ, Gu JY
Neuropsychiatric Disease and Treatment 2018, 14:2105-2114
Published Date: 20 August 2018
Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series
Yamaguchi Y, Kimoto S, Nagahama T, Kishimoto T
Neuropsychiatric Disease and Treatment 2018, 14:2099-2104
Published Date: 17 August 2018
Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
Wang G, You X, Wang X, Xu X, Bai L, Xie J, Yao Z, Yi Q, Ma J, Wang J, Zhuo J, Hu C
Neuropsychiatric Disease and Treatment 2018, 14:2087-2097
Published Date: 14 August 2018
Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases
Bagyinszky E, Giau VV, Youn YC, An SSA, Kim SY
Neuropsychiatric Disease and Treatment 2018, 14:2067-2085
Published Date: 14 August 2018
Clinical characteristics and course of oral somatic delusions: a retrospective chart review of 606 cases in 5 years
Umezaki Y, Miura A, Shinohara Y, Mikuzuki L, Sugawara S, Kawasaki K, Tu TTH, Watanabe T, Suga T, Watanabe M, Takenoshita M, Yoshikawa T, Uezato A, Nishikawa T, Hoshiko K, Naito T, Motomura H, Toyofuku A
Neuropsychiatric Disease and Treatment 2018, 14:2057-2065
Published Date: 13 August 2018
Schizophrenia and risk of dementia: a meta-analysis study
Cai LS, Huang JW
Neuropsychiatric Disease and Treatment 2018, 14:2047-2055
Published Date: 13 August 2018
Social communication disorder: a narrative review on current insights
Topal Z, Demir Samurcu N, Taskiran S, Tufan AE, Semerci B
Neuropsychiatric Disease and Treatment 2018, 14:2039-2046
Published Date: 13 August 2018
Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive–compulsive disorder
Hasanpour H, Ghavamizadeh Meibodi R, Navi K, Asadi S
Neuropsychiatric Disease and Treatment 2018, 14:2027-2038
Published Date: 10 August 2018
Abnormal white matter integrity in Chinese young adults with first-episode medication-free anxious depression: a possible neurological biomarker of subtype major depressive disorder
Xia W, Zhou R, Zhao G, Wang F, Mao R, Peng D, Yang T, Wang Z, Chen J, Fang Y
Neuropsychiatric Disease and Treatment 2018, 14:2017-2026
Published Date: 10 August 2018
Associations between stress and depression symptom profiles vary according to serotonin transporter polymorphism in rural Australians
Sharpley CF, Bitsika V, McMillan ME, Jesulola E, Agnew LL
Neuropsychiatric Disease and Treatment 2018, 14:2007-2016
Published Date: 10 August 2018
Assessment of relevant factors with respect to psychosocial properties in potential living donor candidates before liver transplantation
Wu MK, Hsu LW, Huang KT, Lin CC, Wang CC, Lin TL, Li WF, Goto S, Chen CL, Chen CC
Neuropsychiatric Disease and Treatment 2018, 14:1999-2005
Published Date: 8 August 2018
Resting-state functional changes in the precuneus within first-episode drug-naive patients with MDD
Li G, Rossbach K, Zhang A, Liu P, Zhang K
Neuropsychiatric Disease and Treatment 2018, 14:1991-1998
Published Date: 7 August 2018
Validation of abnormal glucose metabolism associated with Parkinson’s disease in Chinese participants based on 18F-fluorodeoxyglucose positron emission tomography imaging
Jin R, Ge J, Wu P, Lu J, Zhang H, Wang J, Wu J, Han X, Zhang W, Zuo C
Neuropsychiatric Disease and Treatment 2018, 14:1981-1989
Published Date: 6 August 2018
Evaluation of BPPV with vertebral artery values
Yazıcı A, İnanç Y
Neuropsychiatric Disease and Treatment 2018, 14:1975-1979
Published Date: 6 August 2018
Impact of aerobic exercise on muscle mass in patients with major depressive disorder: a randomized controlled trial
Kerling A, Hartung D, Stubbs B, Kück M, Tegtbur U, Grams L, Weber-Spickschen TS, Kahl KG
Neuropsychiatric Disease and Treatment 2018, 14:1969-1974
Published Date: 6 August 2018
Hyperbaric oxygen therapy to improve cognitive dysfunction and encephalatrophy induced by N2O for recreational use: a case report
Luo D, Xu JJ, Hu L, Yu LM, Xie LL, Li J
Neuropsychiatric Disease and Treatment 2018, 14:1963-1967
Published Date: 3 August 2018
Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
Maneeton B, Maneeton N, Likhitsathian S, Woottiluk P, Wiriyacosol P, Boonyanaruthee V, Srisurapanont M
Neuropsychiatric Disease and Treatment 2018, 14:1953-1961
Published Date: 2 August 2018
Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight
Findling RL, Earley W, Suppes T, Patel M, Wu X, Chang CT, McIntyre RS
Neuropsychiatric Disease and Treatment 2018, 14:1941-1952
Published Date: 2 August 2018
Aberrant cortical thickness in neurologically asymptomatic patients with end-stage renal disease
Dong J, Ma X, Lin W, Liu M, Fu S, Yang L, Jiang G
Neuropsychiatric Disease and Treatment 2018, 14:1929-1939
Published Date: 2 August 2018
Tinnitus distress is associated with enhanced resting-state functional connectivity within the default mode network
Chen YC, Chen H, Bo F, Xu JJ, Deng Y, Lv H, Cai Y, Xia W, Yin X, Gu JP, Lu GM
Neuropsychiatric Disease and Treatment 2018, 14:1919-1927
Published Date: 1 August 2018
Cognitive and metacognitive factors among alcohol-dependent patients during a residential rehabilitation program: a pilot study
Torselli E, Ottonello M, Franceschina E, Palagi E, Bertolotti G, Fiabane E
Neuropsychiatric Disease and Treatment 2018, 14:1907-1917
Published Date: 31 July 2018
Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
Kose Ozlece H, Findik Guvendi G, Huseyinoglu N, Ehi Y, Kivrak Y
Neuropsychiatric Disease and Treatment 2018, 14:1901-1906
Published Date: 31 July 2018
Profiling undergraduate students from a Romanian medical university
Romosan RS, Dehelean L, Enatescu VR, Bredicean AC, Papava I, Giurgi-Oncu C, Romosan AM
Neuropsychiatric Disease and Treatment 2018, 14:1891-1899
Published Date: 24 July 2018
Attention-deficit hyperactivity disorder and impulsivity in female patients with fibromyalgia
Yilmaz E, Tamam L
Neuropsychiatric Disease and Treatment 2018, 14:1883-1889
Published Date: 24 July 2018
Alzheimer's disease and blood-based biomarkers – potential contexts of use
Zvěřová M
Neuropsychiatric Disease and Treatment 2018, 14:1877-1882
Published Date: 20 July 2018
Frontal lobe metabolic alterations in autism spectrum disorder: a 1H-magnetic resonance spectroscopy study
Margari L, De Giacomo A, Craig F, Palumbi R, Peschechera A, Margari M, Picardi F, Caldarola M, Maghenzani MA, Dicuonzo F
Neuropsychiatric Disease and Treatment 2018, 14:1871-1876
Published Date: 20 July 2018
Cortical gyrification in schizophrenia: current perspectives
Matsuda Y, Ohi K
Neuropsychiatric Disease and Treatment 2018, 14:1861-1869
Published Date: 19 July 2018
Atrial natriuretic peptide and posterior pituitary neurohormone changes in patients with acute schizophrenia
Guzel D, Yazici AB, Mutu Pek T, Doganay S, Saykan Simsek AB, Saglam K, Turan C, Yazici E
Neuropsychiatric Disease and Treatment 2018, 14:1855-1860
Published Date: 16 July 2018
Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan
Montgomery W, Goren A, Kahle-Wrobleski K, Nakamura T, Ueda K
Neuropsychiatric Disease and Treatment 2018, 14:1843-1854
Published Date: 16 July 2018
Association between peripheral manganese levels and attention-deficit/hyperactivity disorder: a preliminary meta-analysis
Shih JH, Zeng BY, Lin PY, Chen TY, Chen YW, Wu CK, Tseng PT, Wu MK
Neuropsychiatric Disease and Treatment 2018, 14:1831-1842
Published Date: 18 July 2018
A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression
Bangratz M, Ait Abdellah S, Berlin A, Blondeau C, Guilbot A, Dubourdeaux M, Lemoine P
Neuropsychiatric Disease and Treatment 2018, 14:1821-1829
Published Date: 13 July 2018
Risperidone for children and adolescents with autism spectrum disorder: a systematic review
Maneeton N, Maneeton B, Putthisri S, Woottiluk P, Narkpongphun A, Srisurapanont M
Neuropsychiatric Disease and Treatment 2018, 14:1811-1820
Published Date: 11 July 2018
Association between insomnia and coping style in Japanese patients with type 2 diabetes mellitus
Yoshida K, Otaka H, Murakami H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Sugawara N, Nakamura K, Daimon M, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2018, 14:1803-1809
Published Date: 10 July 2018
Gender differences in the protective effects of green tea against amnestic mild cognitive impairment in the elderly Han population
Xu H, Wang Y, Yuan Y, Zhang X, Zuo XY, Cui L, Liu Y, Chen W, Su N, Wang H, Yan F, Li X, Wang T, Xiao S
Neuropsychiatric Disease and Treatment 2018, 14:1795-1801
Published Date: 10 July 2018
Relation of high neuroticism with increased methylation of the BDNF gene
Shirata T, Suzuki A, Matsumoto Y, Takahashi N, Noto K, Goto K, Otani K
Neuropsychiatric Disease and Treatment 2018, 14:1787-1793
Published Date: 9 July 2018
The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats
Wu N, Wan Y, Song L, Qi C, Liu Z, Gan J
Neuropsychiatric Disease and Treatment 2018, 14:1779-1786
Published Date: 5 July 2018
Interstitial deletion within 7q31.1q31.3 in a woman with mild intellectual disability and schizophrenia
Akahoshi K, Yamamoto T
Neuropsychiatric Disease and Treatment 2018, 14:1773-1778
Published Date: 5 July 2018
Ginkgo biloba extract and its diterpene ginkgolide constituents ameliorate the metabolic disturbances caused by recombinant tissue plasminogen activator in rat prefrontal cortex
Chen Z, Bai S, Hu Q, Shen P, Wang T, Liang Z, Wang W, Qi X, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:1755-1772
Published Date: 4 July 2018
Preschool-onset obsessive-compulsive disorder with complete remission
Miyawaki D, Goto A, Iwakura Y, Hirai K, Miki Y, Asada N, Terakawa H, Inoue K
Neuropsychiatric Disease and Treatment 2018, 14:1747-1753
Published Date: 3 July 2018
Changes in synaptic plasticity are associated with electroconvulsive shock-induced learning and memory impairment in rats with depression-like behavior
Chen Q, Ren L, Min S, Hao X, Chen H, Deng J
Neuropsychiatric Disease and Treatment 2018, 14:1737-1746
Published Date: 2 July 2018
Transcranial magnetic stimulation in the treatment of obsessive–compulsive disorder: current perspectives
Lusicic A, Schruers KRJ, Pallanti S, Castle DJ
Neuropsychiatric Disease and Treatment 2018, 14:1721-1736
Published Date: 29 June 2018
Frequency of inborn errors of metabolism screening for children with unexplained acute encephalopathy at an emergency department
Abdel Maksoud M, ELsayed SM, Shatla RH, Imam AA, Elsayed RM, Mosabah AA, Sherif AM
Neuropsychiatric Disease and Treatment 2018, 14:1715-1720
Published Date: 29 June 2018
The effect of depression on fracture healing and osteoblast differentiation in rats
Nie C, Wang Z, Liu X
Neuropsychiatric Disease and Treatment 2018, 14:1705-1713
Published Date: 29 June 2018
A comparison of psychological well-being and quality of life between spouse and non-spouse caregivers in patients with head and neck cancer: a 6-month follow-up study
Lee Y, Lin PY, Chien CY, Fang FM, Wang LJ
Neuropsychiatric Disease and Treatment 2018, 14:1697-1704
Published Date: 28 June 2018
The direct and indirect effects of α-synuclein on microtubule stability in the pathogenesis of Parkinson’s disease
Carnwath T, Mohammed R, Tsiang D
Neuropsychiatric Disease and Treatment 2018, 14:1685-1695
Published Date: 27 June 2018
Clinician-delivered cognitive training for children with attention problems: effects on cognition and behavior from the ThinkRx randomized controlled trial
Moore AL, Carpenter II DM, Miller TM, Ledbetter C
Neuropsychiatric Disease and Treatment 2018, 14:1671-1683
Published Date: 26 June 2018
Neuropsychiatric assessments in patients with multiple sclerosis in early phases and with low disability
Schmidt SL, Santos da Silva M, Schmidt JJ, Carvalho ALN, Vasconcelos CCF, Paes RA, Boechat YEM, Neder R, Alvarenga RP
Neuropsychiatric Disease and Treatment 2018, 14:1665-1670
Published Date: 22 June 2018
COMT Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia
Kaneko H, Miura I, Kanno-Nozaki K, Horikoshi S, Hino M, Yabe H
Neuropsychiatric Disease and Treatment 2018, 14:1657-1663
Published Date: 22 June 2018
Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life
Cuomo I, Kotzalidis GD, de Persis S, Piacentino D, Perrini F, Amici E, De Filippis S
Neuropsychiatric Disease and Treatment 2018, 14:1645-1656
Published Date: 21 June 2018
The detection of white matter alterations in obsessive–compulsive disorder revealed by TRActs Constrained by UnderLying Anatomy (TRACULA)
Watanabe A, Nakamae T, Sakai Y, Nishida S, Abe Y, Yamada K, Yokota I, Narumoto J
Neuropsychiatric Disease and Treatment 2018, 14:1635-1643
Published Date: 19 June 2018
The role of MAPT gene in Chinese dementia patients: a P301L pedigree study and brief literature review
He S, Chen S, Xia MR, Sun ZK, Huang Y, Zhang JW
Neuropsychiatric Disease and Treatment 2018, 14:1627-1633
Published Date: 18 June 2018
Vibration therapy in patients with cerebral palsy: a systematic review
Ritzmann R, Stark C, Krause A
Neuropsychiatric Disease and Treatment 2018, 14:1607-1625
Published Date: 18 June 2018
Mindfulness-based cognitive therapy in patients with depression: current perspectives
MacKenzie MB, Abbott KA, Kocovski NL
Neuropsychiatric Disease and Treatment 2018, 14:1599-1605
Published Date: 18 June 2018
Structural equation modeling approach between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia: an ICA resting-state fMRI study
Ohta M, Nakataki M, Takeda T, Numata S, Tominaga T, Kameoka N, Kubo H, Kinoshita M, Matsuura K, Otomo M, Takeichi N, Harada M, Ohmori T
Neuropsychiatric Disease and Treatment 2018, 14:1585-1597
Published Date: 15 June 2018
Early antipsychotic treatment in juvenile rats elicits long-term alterations to the adult serotonin receptors
De Santis M, Huang XF, Deng C
Neuropsychiatric Disease and Treatment 2018, 14:1569-1583
Published Date: 14 June 2018
Effects of sequential nutritional support on nutritional status and expression of regulatory T lymphocyte in patients with early severe traumatic brain injury
Jia K, Tong X, Liang F
Neuropsychiatric Disease and Treatment 2018, 14:1561-1567
Published Date: 14 June 2018
Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA
Greene M, Paladini L, Lemmer T, Piedade A, Touya M, Clark O
Neuropsychiatric Disease and Treatment 2018, 14:1545-1559
Published Date: 14 June 2018
Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations
Mayerova M, Ustohal L, Jarkovsky J, Pivnicka J, Kasparek T, Ceskova E
Neuropsychiatric Disease and Treatment 2018, 14:1535-1543
Published Date: 14 June 2018
Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial
Che T, Teng X, Huang Q, Mu Y, Tang X, Mu X, Wei Y
Neuropsychiatric Disease and Treatment 2018, 14:1527-1533
Published Date: 13 June 2018
Risk assessment of night-eating syndrome occurrence in women in Poland, considering the obesity factor in particular
Olejniczak D, Bugajec D, Staniszewska A, Panczyk M, Kielan A, Czerw A, Mańczuk M, Juszczyk G, Skonieczna J, Brytek-Matera A
Neuropsychiatric Disease and Treatment 2018, 14:1521-1526
Published Date: 13 June 2018
Addictive potential of novel treatments for refractory depression and anxiety
Kolar D
Neuropsychiatric Disease and Treatment 2018, 14:1513-1519
Published Date: 12 June 2018
The effect of evening primrose oil on fatigue and quality of life in patients with multiple sclerosis
Majdinasab N, Namjoyan F, Taghizadeh M, Saki H
Neuropsychiatric Disease and Treatment 2018, 14:1505-1512
Published Date: 12 June 2018
Electroencephalogram alpha asymmetry in patients with depressive disorders: current perspectives
Kaiser AK, Gnjezda MT, Knasmüller S, Aichhorn W
Neuropsychiatric Disease and Treatment 2018, 14:1493-1504
Published Date: 11 June 2018
Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
Sajatovic M, Ross R, Legacy SN, Byerly M, Kane JM, DiBiasi F, Fitzgerald H, Correll CU
Neuropsychiatric Disease and Treatment 2018, 14:1475-1492
Published Date: 8 June 2018
Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1
Sajatovic M, Ross R, Legacy SN, Correll CU, Kane JM, DiBiasi F, Fitzgerald H, Byerly M
Neuropsychiatric Disease and Treatment 2018, 14:1463-1474
Published Date: 8 June 2018
Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics
Gui SW, Liu YY, Zhong XG, Liu XY, Zheng P, Pu JC, Zhou J, Chen JJ, Zhao LB, Liu LX, Xu GW, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:1451-1461
Published Date: 6 June 2018
A review of ketamine’s role in ECT and non-ECT settings
Jankauskas V, Necyk C, Chue J, Chue P
Neuropsychiatric Disease and Treatment 2018, 14:1437-1450
Published Date: 6 June 2018
Misdiagnosed atypical paroxysmal kinesigenic dyskinesia: a case report
Pan F, Li S, Li H, Xu Y, Huang M
Neuropsychiatric Disease and Treatment 2018, 14:1433-1435
Published Date: 5 June 2018
Investigation on dysfunctional beliefs and attitudes about sleep in Chinese college students
Jin LR, Zhou J, Peng H, Ding SS, Yuan H
Neuropsychiatric Disease and Treatment 2018, 14:1425-1432
Published Date: 1 June 2018
Suicidality, self-stigma, social anxiety and personality traits in stabilized schizophrenia patients – a cross-sectional study
Vrbova K, Prasko J, Ociskova M, Holubova M, Kantor K, Kolek A, Grambal A, Slepecky M
Neuropsychiatric Disease and Treatment 2018, 14:1415-1424
Published Date: 1 June 2018
Acetaminophen, antibiotics, ear infection, breastfeeding, vitamin D drops, and autism: an epidemiological study
Bittker SS, Bell KR
Neuropsychiatric Disease and Treatment 2018, 14:1399-1414
Published Date: 31 May 2018
Memantine induces manic episode in a 73-year-old patient with vascular neurocognitive disorder: a case report
Duan JF, Lao CM, Chen JK, Pan F, Zhang CL, Xu WJ, Zhou WH, Hu JB, Shang DS, Huang ML, Xu Y
Neuropsychiatric Disease and Treatment 2018, 14:1395-1398
Published Date: 30 May 2018
Musical dual-task training in patients with mild-to-moderate dementia: a randomized controlled trial
Chen YL, Pei YC
Neuropsychiatric Disease and Treatment 2018, 14:1381-1393
Published Date: 30 May 2018
Mothers and fathers of children with epilepsy: gender differences in post-traumatic stress symptoms and correlations with mood spectrum symptoms
Carmassi C, Corsi M, Bertelloni CA, Carpita B, Gesi C, Pedrinelli V, Massimetti G, Peroni DG, Bonuccelli A, Orsini A, Dell’Osso L
Neuropsychiatric Disease and Treatment 2018, 14:1371-1379
Published Date: 25 May 2018
Incidence of venous thromboembolism in psychiatric inpatients: a chart review
Takeshima M, Ishikawa H, Shimizu K, Kanbayashi T, Shimizu T
Neuropsychiatric Disease and Treatment 2018, 14:1363-1370
Published Date: 23 May 2018
Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects
Cheng T, Wallace DM, Ponteri B, Tuli M
Neuropsychiatric Disease and Treatment 2018, 14:1351-1361
Published Date: 23 May 2018
Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
Saragoussi D, Christensen MC, Hammer-Helmich L, Rive B, Touya M, Haro JM
Neuropsychiatric Disease and Treatment 2018, 14:1339-1350
Published Date: 22 May 2018
Six months methylphenidate treatment improves emotion dysregulation in adolescents with attention deficit/hyperactivity disorder: a prospective study
Suzer Gamli I, Tahiroglu AY
Neuropsychiatric Disease and Treatment 2018, 14:1329-1337
Published Date: 22 May 2018
The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients
Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2018, 14:1319-1327
Published Date: 22 May 2018
Effects of traditional and cyber homophobic bullying in childhood on depression, anxiety, and physical pain in emerging adulthood and the moderating effects of social support among gay and bisexual men in Taiwan
Wang CC, Lin HC, Chen MH, Ko NY, Chang YP, Lin IM, Yen CF
Neuropsychiatric Disease and Treatment 2018, 14:1309-1317
Published Date: 22 May 2018
Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T
Neuropsychiatric Disease and Treatment 2018, 14:1307-1308
Published Date: 22 May 2018
Comparative efficacy and safety of Crocus sativus L. for treating mild to moderate major depressive disorder in adults: a meta-analysis of randomized controlled trials
Yang XY, Chen XL, Fu YX, Luo QH, Du L, Qiu HT, Qiu T, Zhang L, Meng HQ
Neuropsychiatric Disease and Treatment 2018, 14:1297-1305
Published Date: 21 May 2018
Differences in psychopathology and behavioral characteristics of patients affected by conversion motor disorder and organic dystonia
Pastore A, Pierri G, Fabio G, Ferramosca S, Gigante A, Superbo M, Pellicciari R, Margari F
Neuropsychiatric Disease and Treatment 2018, 14:1287-1295
Published Date: 18 May 2018
Low dose of aripiprazole advanced sleep rhythm and reduced nocturnal sleep time in the patients with delayed sleep phase syndrome: an open-labeled clinical observation
Omori Y, Kanbayashi T, Sagawa Y, Imanishi A, Tsutsui K, Takahashi Y, Takeshima M, Takaki M, Nishino S, Shimizu T
Neuropsychiatric Disease and Treatment 2018, 14:1281-1286
Published Date: 18 May 2018
Harm avoidance and depression, anxiety, insomnia, and migraine in fifth-year medical students in Taiwan
Chen CY, Yu NW, Huang TH, Wang WS, Fang JT
Neuropsychiatric Disease and Treatment 2018, 14:1273-1280
Published Date: 16 May 2018
Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan
Watanabe Y, Asami Y, Hirano Y, Kuribayashi K, Itamura R, Imaeda T
Neuropsychiatric Disease and Treatment 2018, 14:1261-1272
Published Date: 16 May 2018
Effect of serum inflammatory markers on the prognosis of adult and pediatric patients with Guillain–Barré syndrome
Ethemoglu O, Calik M
Neuropsychiatric Disease and Treatment 2018, 14:1255-1260
Published Date: 15 May 2018
Aggressiveness, violence, homicidality, homicide, and Lyme disease
Greenberg R
Neuropsychiatric Disease and Treatment 2018, 14:1253-1254
Published Date: 14 May 2018
Synchronization within, and interactions between, the default mode and dorsal attention networks in relapsing-remitting multiple sclerosis
Huang M, Zhou F, Wu L, Wang B, Wan H, Li F, Zeng X, Gong H
Neuropsychiatric Disease and Treatment 2018, 14:1241-1252
Published Date: 14 May 2018
Disrupted interhemispheric functional connectivity in chronic insomnia disorder: a resting-state fMRI study
Zhou F, Zhao Y, Huang M, Zeng X, Wang B, Gong H
Neuropsychiatric Disease and Treatment 2018, 14:1229-1240
Published Date: 14 May 2018
Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial
Musil F, Pokladnikova J, Pavelek Z, Wang B, Guan X, Valis M
Neuropsychiatric Disease and Treatment 2018, 14:1221-1228
Published Date: 10 May 2018
Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review
Masopust J, Protopopová D, Vališ M, Pavelek Z, Klímová B
Neuropsychiatric Disease and Treatment 2018, 14:1211-1220
Published Date: 9 May 2018
Association of serotonin receptor 2a haplotypes with obsessive–compulsive disorder and its treatment response in Iranian patients: a genetic and pharmacogenetic study
Sina M, Ahmadiani A, Asadi S, Shams J
Neuropsychiatric Disease and Treatment 2018, 14:1199-1209
Published Date: 9 May 2018
Prefrontoparietal dysfunction during emotion regulation in anxiety disorder: a meta-analysis of functional magnetic resonance imaging studies
Wang HY, Zhang XX, Si CP, Xu Y, Liu Q, Bian HT, Zhang BW, Li XL, Yan ZR
Neuropsychiatric Disease and Treatment 2018, 14:1183-1198
Published Date: 9 May 2018
The impact of total sleep deprivation upon cognitive functioning in firefighters
Kujawski S, Słomko J, Tafil-Klawe M, Zawadka-Kunikowska M, Szrajda J, Newton JL, Zalewski P, Klawe JJ
Neuropsychiatric Disease and Treatment 2018, 14:1171-1181
Published Date: 8 May 2018
Children with autism spectrum disorders and selective mutism
Steffenburg H, Steffenburg S, Gillberg C, Billstedt E
Neuropsychiatric Disease and Treatment 2018, 14:1163-1169
Published Date: 7 May 2018
Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden – a longitudinal population-based register study
Polyzoi M, Ahnemark E, Medin E, Ginsberg Y
Neuropsychiatric Disease and Treatment 2018, 14:1149-1161
Published Date: 7 May 2018
The effects of Maras powder use on patients with migraine
İnanç Y, Orhan FÖ, İnanç Y
Neuropsychiatric Disease and Treatment 2018, 14:1143-1148
Published Date: 7 May 2018
Allergy to chlorpromazine and valproic acid following carbamazepine hypersensitivity in a patient with an HLA-B*4601 allele
Sakurada K, Kozaru T, Yamada K, Nibuya M, Nagata K, Suzuki E
Neuropsychiatric Disease and Treatment 2018, 14:1139-1142
Published Date: 4 May 2018
Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion
Veselinović T, Vernaleken I, Cumming P, Henning U, Winkler L, Kaleta P, Paulzen M, Luckhaus C, Gründer G
Neuropsychiatric Disease and Treatment 2018, 14:1125-1138
Published Date: 27 April 2018
Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study
Kongsaengdao S, Maneeton N, Maneeton B
Neuropsychiatric Disease and Treatment 2018, 14:1119-1124
Published Date: 26 April 2018
Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study
Li H, Li Y, Feng Y, Zhuo J, Turkoz I, Mathews M, Tan W
Neuropsychiatric Disease and Treatment 2018, 14:1107-1117
Published Date: 26 April 2018
Antidepressant medication use and nasopharyngeal cancer risk: a nationwide population-based study
Lin C, Chan HL, Hsieh YH, Liang H, Chiu WC, Lee Y, McIntyre RS, Chen VC
Neuropsychiatric Disease and Treatment 2018, 14:1101-1106
Published Date: 30 April 2018
New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab
Frau J, Coghe G, Lorefice L, Fenu G, Cocco E
Neuropsychiatric Disease and Treatment 2018, 14:1093-1099
Published Date: 23 April 2018
Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
Katagiri H, Taketsuna M, Kondo S, Kajimoto K, Aoi E, Tanji Y
Neuropsychiatric Disease and Treatment 2018, 14:1083-1091
Published Date: 23 April 2018
Comparison of changes in oxygenated hemoglobin during the tree-drawing task between patients with schizophrenia and healthy controls
Nakano S, Shoji Y, Morita K, Igimi H, Sato M, Ishii Y, Kondo A, Uchimura N
Neuropsychiatric Disease and Treatment 2018, 14:1071-1082
Published Date: 20 April 2018
Aberrant brain functional connectome in patients with obstructive sleep apnea
Chen L, Fan X, Li H, Ye C, Yu H, Xin H, Gong H, Peng D, Yan L
Neuropsychiatric Disease and Treatment 2018, 14:1059-1070
Published Date: 18 April 2018
Electroconvulsive therapy in 77-year-old patient with pacemaker: a case report
Mędrala T, Pycińska A, Pyciński B, Merk W, Kucia K
Neuropsychiatric Disease and Treatment 2018, 14:1055-1058
Published Date: 17 April 2018
REAC neuromodulation treatments in subjects with severe socioeconomic and cultural hardship in the Brazilian state of Pará: a family observational pilot study
Coelho Pereira JA, Rinaldi A, Fontani V, Rinaldi S
Neuropsychiatric Disease and Treatment 2018, 14:1047-1054
Published Date: 16 April 2018
Significant association of BDNF rs6265 G>A polymorphism with susceptibility to epilepsy: a meta-analysis
Xu Y, Li X, Zhuang S, Guo S, Xiang J, Wang L, Zhou L, Wu B
Neuropsychiatric Disease and Treatment 2018, 14:1035-1046
Published Date: 16 April 2018
Gender-specific association of functional prodynorphin 68 bp repeats with cannabis exposure in an African American cohort
Yuferov V, Butelman ER, Kreek MJ
Neuropsychiatric Disease and Treatment 2018, 14:1025-1034
Published Date: 16 April 2018
Does higher severity really correlate with a worse quality of life in obsessive–compulsive disorder? A meta-regression
Pozza A, Lochner C, Ferretti F, Cuomo A, Coluccia A
Neuropsychiatric Disease and Treatment 2018, 14:1013-1023
Published Date: 16 April 2018
Metabolite-related antidepressant action of diterpene ginkgolides in the prefrontal cortex
Hu Q, Shen P, Bai S, Dong M, Liang Z, Chen Z, Wang W, Wang H, Gui S, Li P, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:999-1011
Published Date: 13 April 2018
The functional and structural characteristics of the emotion network in alexithymia
Han D, Li M, Mei MJ, Sun XF
Neuropsychiatric Disease and Treatment 2018, 14:991-998
Published Date: 12 April 2018
The effects of psychoeducational family intervention on coping strategies of relatives of patients with bipolar I disorder: results from a controlled, real-world, multicentric study
Sampogna G, Luciano M, Del Vecchio V, Malangone C, De Rosa C, Giallonardo V, Borriello G, Pocai B, Savorani M, Steardo L Jr, Lampis D, Veltro F, Bartoli F, Bardicchia F, Moroni AM, Ciampini G, Orlandi E, Ferrari S, Biondi S, Iapichino S, Pompili E, Piselli M, Tortorella A, Carrà G, Fiorillo A
Neuropsychiatric Disease and Treatment 2018, 14:977-989
Published Date: 11 April 2018
Insomnia in hospitalized psychiatric patients: prevalence and associated factors
Talih F, Ajaltouni J, Ghandour H, Abu-Mohammad AS, Kobeissy F
Neuropsychiatric Disease and Treatment 2018, 14:969-975
Published Date: 10 April 2018
Prospective interepisodal mood monitoring in patients with affective disorders: a feasibility study [Corrigendum]
Van der Watt ASJ, Suryapranata APSP, Seedat S
Neuropsychiatric Disease and Treatment 2018, 14:967-968
Published Date: 10 April 2018
Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study
Otsubo T, Watanabe Y, Hongo S, Inoue M, Akimoto K, Murakami K, Takahashi R, Kikuchi T
Neuropsychiatric Disease and Treatment 2018, 14:955-966
Published Date: 6 April 2018
Elevated peripheral blood glutamate levels in major depressive disorder
Inoshita M, Umehara H, Watanabe S, Nakataki M, Kinoshita M, Tomioka Y, Tajima A, Numata S, Ohmori T
Neuropsychiatric Disease and Treatment 2018, 14:945-953
Published Date: 6 April 2018
Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats
Kanada Y, Katayama A, Ikemoto H, Takahashi K, Tsukada M, Nakamura A, Ishino S, Hisamitsu T, Sunagawa M
Neuropsychiatric Disease and Treatment 2018, 14:937-944
Published Date: 6 April 2018
Laxative use and clinical correlates in hospitalized patients with obsessive-compulsive disorder: a retrospective descriptive study
Lai JB, Zhou WH, Lu QQ, Huang TT, Xu Y, Hu SH
Neuropsychiatric Disease and Treatment 2018, 14:933-936
Published Date: 5 April 2018
Von Economo’s disease and postencephalitic parkinsonism responsive to carbidopa and levodopa
Bigman DY, Bobrin BD
Neuropsychiatric Disease and Treatment 2018, 14:927-931
Published Date: 4 April 2018
Investigation of variants in estrogen receptor genes and perinatal depression
Tan EC, Lim HW, Chua TE, Tan HS, Lee TMY, Chen HY
Neuropsychiatric Disease and Treatment 2018, 14:919-925
Published Date: 29 March 2018
Ten-year outcome of vagus nerve stimulation-implanted patients with treatment-resistant depression: two Italian cases
Dell'Osso B, Oldani L, Grancini B, Dario A, Altamura AC
Neuropsychiatric Disease and Treatment 2018, 14:915-918
Published Date: 29 March 2018
Psychometric properties of the Patient Dignity Inventory in an acute psychiatric ward: an extension study of the preliminary validation
Di Lorenzo R, Ferri P, Biffarella C, Cabri G, Carretti E, Pollutri G, Spattini L, Del Giovane C, Chochinov HM
Neuropsychiatric Disease and Treatment 2018, 14:903-913
Published Date: 29 March 2018
Association of high psychiatrist staffing with prolonged hospitalization, follow-up visits, and readmission in acute psychiatric units: a retrospective cohort study using a nationwide claims database
Okumura Y, Sugiyama N, Noda T, Sakata N
Neuropsychiatric Disease and Treatment 2018, 14:893-902
Published Date: 28 March 2018
The acceptability of an Internet-based exposure treatment for flying phobia with and without therapist guidance: patients’ expectations, satisfaction, treatment preferences, and usability
Campos D, Mira A, Bretón-López J, Castilla D, Botella C, Baños RM, Quero S
Neuropsychiatric Disease and Treatment 2018, 14:879-892
Published Date: 28 March 2018
Correlation between cognitive impairment during the acute phase of first cerebral infarction and development of long-term pseudobulbar affect
Wang Y, Wang Y, Ma W, Lu S, Chen J, Cao L
Neuropsychiatric Disease and Treatment 2018, 14:871-877
Published Date: 28 March 2018
Phenotypic characterization of an older adult male with late-onset epilepsy and a novel mutation in ASXL3 shows overlap with the associated Bainbridge-Ropers syndrome
Verhoeven W, Egger J, Räkers E, van Erkelens A, Pfundt R, Willemsen MH
Neuropsychiatric Disease and Treatment 2018, 14:867-870
Published Date: 27 March 2018
Marked differences in core beliefs about self and others, between sociotropy and autonomy: personality vulnerabilities in the cognitive model of depression
Otani K, Suzuki A, Matsumoto Y, Shirata T
Neuropsychiatric Disease and Treatment 2018, 14:863-866
Published Date: 27 March 2018
Serum levels of GPER -1 in euthymic bipolar patients
Orhan FÖ, Kurutaş EB, Doğaner A, Türker E, Taner Özcü SŞ, Güngör M, Çakmak S
Neuropsychiatric Disease and Treatment 2018, 14:855-862
Published Date: 26 March 2018
Aberrant regional brain activities in alcohol dependence: a functional magnetic resonance imaging study
Tu XZ, Wang JJ, Liu XM, Zheng JY
Neuropsychiatric Disease and Treatment 2018, 14:847-853
Published Date: 22 March 2018
Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson’s disease
Hauser RA, Ellenbogen A, Khanna S, Gupta S, Modi NB
Neuropsychiatric Disease and Treatment 2018, 14:839-845
Published Date: 22 March 2018
Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics
Li N, Feng Y, Lu HF, Cai SL, Zhuo JM, Si TM, Zhang LL
Neuropsychiatric Disease and Treatment 2018, 14:825-837
Published Date: 22 March 2018
Dysfunction of cortical synapse-specific mitochondria in developing rats exposed to lead and its amelioration by ascorbate supplementation
Ahmad F, Salahuddin M, Alamoudi W, Acharya S
Neuropsychiatric Disease and Treatment 2018, 14:813-824
Published Date: 21 March 2018
A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report
Alamri SH
Neuropsychiatric Disease and Treatment 2018, 14:809-811
Published Date: 20 March 2018
Serum levels of β-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study
Huang YC, Lin PY, Lee Y, Hung CF, Hsu ST, Wu CC, Wang LJ
Neuropsychiatric Disease and Treatment 2018, 14:799-808
Published Date: 19 March 2018
Beneficial effects of trimetazidine on expression of serotonin and serotonin transporter in rats with myocardial infarction and depression
Liu MY, Wei WL, Stone CR, Zhang LJ, Tian GX, Ding JN
Neuropsychiatric Disease and Treatment 2018, 14:787-797
Published Date: 16 March 2018
Continuous performance task in ADHD: Is reaction time variability a key measure?
Levy F, Pipingas A, Harris EV, Farrow M, Silberstein RB
Neuropsychiatric Disease and Treatment 2018, 14:781-786
Published Date: 15 March 2018
A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy
Zhang LL, Wang CZ, Li W
Neuropsychiatric Disease and Treatment 2018, 14:769-779
Published Date: 14 March 2018
Therapeutic deep brain stimulation worsening dysprosody in Parkinson’s disease – an unexplored entity
Shoaib M, Khan MT
Neuropsychiatric Disease and Treatment 2018, 14:767-768
Published Date: 13 March 2018
Association between etiology and lesion site in ischemic brainstem infarcts: a retrospective observational study
Baran G, Ozdemir Gultekin T, Baran O, Deniz C, Katar S, Babacan Yildiz G, Asil T
Neuropsychiatric Disease and Treatment 2018, 14:757-766
Published Date: 13 March 2018
Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: an open-label pilot study
Antczak J, Kowalska K, Klimkowicz-Mrowiec A, Wach B, Kasprzyk K, Banach M, Rzeźnicka-Brzegowy K, Kubica J, Słowik A
Neuropsychiatric Disease and Treatment 2018, 14:749-755
Published Date: 13 March 2018
Novel treatment options in depression and psychosis
Ceskova E, Silhan P
Neuropsychiatric Disease and Treatment 2018, 14:741-747
Published Date: 13 March 2018
Secondary central nervous system lymphoma: spectrum of morphological MRI appearances
Malikova H, Burghardtova M, Koubska E, Mandys V, Kozak T, Weichet J
Neuropsychiatric Disease and Treatment 2018, 14:733-740
Published Date: 12 March 2018
Efficacy, tolerability, and safety of oral paliperidone extended release in the treatment of schizophrenia: a 24-week, open-label, prospective switch study in different settings in Taiwan
Chen CY, Tang TC, Chen TT, Bai YM, Tsai HH, Chen HL, Huang CJ, Chen CK, Chen CC, Hsiao MC, Liu CY, Yeh HS, Chiu NY, Hsiao CC, Chen CS, Su TP
Neuropsychiatric Disease and Treatment 2018, 14:725-732
Published Date: 8 March 2018
Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response
Zeng D, He S, Yu S, Li G, Ma C, Wen Y, Shen Y, Yu Y, Li H
Neuropsychiatric Disease and Treatment 2018, 14:715-723
Published Date: 8 March 2018
Aggressiveness, violence, homicidality, homicide, and Lyme disease
Bransfield RC
Neuropsychiatric Disease and Treatment 2018, 14:693-713
Published Date: 9 March 2018
The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment
Tompsett T, Masters K, Donyai P
Neuropsychiatric Disease and Treatment 2018, 14:681-691
Published Date: 2 March 2018
Evaluating psychiatric readmissions in the emergency department of a large public hospital
Morris DW, Ghose S, Williams E, Brown K, Khan F
Neuropsychiatric Disease and Treatment 2018, 14:671-679
Published Date: 1 March 2018
A cross-sectional study exploring useful indicators for low bone mineral density in male alcoholic patients
Horai T, Hishimoto A, Otsuka I, So T, Mouri K, Shimmyo N, Boku S, Okishio N, Sora I
Neuropsychiatric Disease and Treatment 2018, 14:663-669
Published Date: 28 February 2018
Manic behavior and asymmetric right frontotemporal dementia from a novel progranulin mutation
Mendez MF
Neuropsychiatric Disease and Treatment 2018, 14:657-662
Published Date: 26 February 2018
Sex differences in gut microbiota in patients with major depressive disorder
Chen JJ, Zheng P, Liu YY, Zhong XG, Wang HY, Guo YJ, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:647-655
Published Date: 26 February 2018
Childhood trauma and dissociation among women with genito-pelvic pain/penetration disorder
Özen B, Özdemir YO, Beştepe EE
Neuropsychiatric Disease and Treatment 2018, 14:641-646
Published Date: 23 February 2018
Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients
Hamdy SM, Abdel-Naseer M, Shalaby NM, Elmazny A, Girgis M, Nada MA, Hassan A, Mourad HS, Hegazy MI, Abdelalim A, Kishk NA, Abokrysha NT, Genedy SA, Essawy EA, Shehata HS
Neuropsychiatric Disease and Treatment 2018, 14:631-640
Published Date: 23 February 2018
The effectiveness of parent participation in occupational therapy for children with developmental delay
Lin CL, Lin CK, Yu JJ
Neuropsychiatric Disease and Treatment 2018, 14:623-630
Published Date: 23 February 2018
Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine
Imagawa H, Nagar SP, Montgomery W, Nakamura T, Sato M, Davis KL
Neuropsychiatric Disease and Treatment 2018, 14:611-621
Published Date: 22 February 2018
Successful switch from bilateral brief pulse to right unilateral ultrabrief pulse electroconvulsive therapy after failure to induce seizures
Kawashima H, Kobayashi Y, Suwa T, Murai T, Yoshioka R
Neuropsychiatric Disease and Treatment 2018, 14:607-610
Published Date: 21 February 2018
IQ discrepancy differentiates levels of fine motor skills and their relationship in children with autism spectrum disorders
Yu TY, Chou W, Chow JC, Lin CH, Tung LC, Chen KL
Neuropsychiatric Disease and Treatment 2018, 14:597-605
Published Date: 20 February 2018
High serum levels of 8-OHdG are an independent predictor of post-stroke depression in Chinese stroke survivors
Liu ZH, Cai Y, He J
Neuropsychiatric Disease and Treatment 2018, 14:587-596
Published Date: 19 February 2018
Vitamin D and vitamin D receptor levels in children with attention-deficit/hyperactivity disorder
Sahin N, Altun H, Kurutas EB, Balkan D
Neuropsychiatric Disease and Treatment 2018, 14:581-585
Published Date: 19 February 2018
Drug–drug interactions involving antidepressants: focus on desvenlafaxine
Low Y, Setia S, Lima G
Neuropsychiatric Disease and Treatment 2018, 14:567-580
Published Date: 19 February 2018
Human factors evaluation of a novel digital medicine system in psychiatry
Peters-Strickland T, Hatch A, Adenwala A, Atkinson K, Bartfeld B
Neuropsychiatric Disease and Treatment 2018, 14:553-565
Published Date: 16 February 2018
Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
Chen JW, Xie SQ
Neuropsychiatric Disease and Treatment 2018, 14:547-552
Published Date: 16 February 2018
Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies
Citrome L, Kando JC, Bliss C
Neuropsychiatric Disease and Treatment 2018, 14:537-546
Published Date: 15 February 2018
Anti-TNF-alpha antibody attenuates subarachnoid hemorrhage-induced apoptosis in the hypothalamus by inhibiting the activation of Erk
Ma L, Jiang Y, Dong YN, Gao J, Du B, Liu DW
Neuropsychiatric Disease and Treatment 2018, 14:525-536
Published Date: 15 February 2018
Prospective interepisodal mood monitoring in patients with affective disorders: a feasibility study
Van der Watt ASJ, Suryapranata APSP, Seedat S
Neuropsychiatric Disease and Treatment 2018, 14:517-524
Published Date: 14 February 2018
Corpus callosum infarction with cognitive dysfunction: two case reports and literature review
Zhang J, Tang Y, Sun Y, Xu Y, Pang L, Li J, Wu T, He M
Neuropsychiatric Disease and Treatment 2018, 14:511-515
Published Date: 13 February 2018
Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation
Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2018, 14:505-510
Published Date: 12 February 2018
Glia maturation factor-β: a potential therapeutic target in neurodegeneration and neuroinflammation
Fan J, Fong T, Chen X, Chen C, Luo P, Xie H
Neuropsychiatric Disease and Treatment 2018, 14:495-504
Published Date: 9 February 2018
The effect of exercise on cancer-related fatigue in cancer survivors: a systematic review and meta-analysis
Kessels E, Husson O, van der Feltz-Cornelis CM
Neuropsychiatric Disease and Treatment 2018, 14:479-494
Published Date: 9 February 2018
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
Luan SX, Wan HQ, Zhang L, Zhao H
Neuropsychiatric Disease and Treatment 2018, 14:467-477
Published Date: 8 February 2018
Application value of selected serum indicators in the differential diagnosis of geriatric depression and transient depressive state
Xu Y, Yao S, Wei H, Zhu X, Yu M, Li Y
Neuropsychiatric Disease and Treatment 2018, 14:459-465
Published Date: 8 February 2018
Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness
Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T
Neuropsychiatric Disease and Treatment 2018, 14:451-457
Published Date: 8 February 2018
Suicidal drug overdose following stroke in elderly patients: a retrospective population-based cohort study
Chang CH, Chen SJ, Liu CY, Tsai HC
Neuropsychiatric Disease and Treatment 2018, 14:443-450
Published Date: 7 February 2018
The differences between patients with panic disorder and healthy controls in psychophysiological stress profile
Kotianova A, Kotian M, Slepecky M, Chupacova M, Prasko J, Tonhajzerova I
Neuropsychiatric Disease and Treatment 2018, 14:435-441
Published Date: 7 February 2018
Discrepancy in Taiwanese psychiatrists’ preferences for long-acting injectable antipsychotics across facilities: a nationwide questionnaire survey
Liu CH, Tsai PH, Chen CY
Neuropsychiatric Disease and Treatment 2018, 14:429-433
Published Date: 1 February 2018
Association of the matrix metalloproteinase-3 polymorphisms rs679620 and rs3025058 with ischemic stroke risk: a meta-analysis
Zhang Q
Neuropsychiatric Disease and Treatment 2018, 14:419-427
Published Date: 31 January 2018
Chinese calligraphy handwriting (CCH): a case of rehabilitative awakening of a coma patient after stroke
Kao HSR, Lam SPW, Kao TT
Neuropsychiatric Disease and Treatment 2018, 14:407-417
Published Date: 31 January 2018
Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson’s disease
Berardelli I, Bloise MC, Bologna M, Conte A, Pompili M, Lamis DA, Pasquini M, Fabbrini G
Neuropsychiatric Disease and Treatment 2018, 14:399-405
Published Date: 26 January 2018
Color preferences in participants with high or low hypnotic susceptibility
Yu E, Zhu J, Tan Y, Liao Z, Qiu Y, Zhang B, Wang C, Wang W
Neuropsychiatric Disease and Treatment 2018, 14:393-398
Published Date: 30 January 2018
Self-stigma and treatment effectiveness in patients with anxiety disorders – a mediation analysis
Ociskova M, Prasko J, Vrbova K, Kasalova P, Holubova M, Grambal A, Machu K
Neuropsychiatric Disease and Treatment 2018, 14:383-392
Published Date: 26 January 2018
Adjustment disorder: current perspectives
Zelviene P, Kazlauskas E
Neuropsychiatric Disease and Treatment 2018, 14:375-381
Published Date: 25 January 2018
Oxidative/antioxidative status, lymphocyte DNA damage, and urotensin-2 receptor level in patients with migraine attacks
Yigit M, Sogut O, Tataroglu Ö, Yamanoglu A, Yigit E, Guler EM, Ozer OF, Kocyigit A
Neuropsychiatric Disease and Treatment 2018, 14:367-374
Published Date: 24 January 2018
Comparative efficacy and acceptability of bibliotherapy for depression and anxiety disorders in children and adolescents: a meta-analysis of randomized clinical trials
Yuan S, Zhou X, Zhang Y, Zhang H, Pu J, Yang L, Liu L, Jiang X, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:353-365
Published Date: 24 January 2018
The impact of age of onset on amygdala intrinsic connectivity in major depression
Clark DL, Konduru N, Kemp A, Bray S, Brown EC, Goodyear B, Ramasubbu R
Neuropsychiatric Disease and Treatment 2018, 14:343-352
Published Date: 22 January 2018
Failure to improve after ovarian resection could be a marker of recurrent ovarian teratoma in anti-NMDAR encephalitis: a case report
Uchida Y, Kato D, Yamashita Y, Ozaki Y, Matsukawa N
Neuropsychiatric Disease and Treatment 2018, 14:339-342
Published Date: 22 January 2018
Reflex epilepsy: triggers and management strategies
Okudan ZV, Özkara Ç
Neuropsychiatric Disease and Treatment 2018, 14:327-337
Published Date: 18 January 2018
Systematic review of catatonia treatment
Pelzer ACM, van der Heijden FMMA, den Boer E
Neuropsychiatric Disease and Treatment 2018, 14:317-326
Published Date: 17 January 2018
Efficacy of twice-daily vs once-daily sessions of repetitive transcranial magnetic stimulation in the treatment of major depressive disorder: a retrospective study
Modirrousta M, Meek BP, Wikstrom SL
Neuropsychiatric Disease and Treatment 2018, 14:309-316
Published Date: 17 January 2018
“Low road” to rehabilitation: a perspective on subliminal sensory neuroprosthetics
Ghai S, Ghai I, Effenberg AO
Neuropsychiatric Disease and Treatment 2018, 14:301-307
Published Date: 17 January 2018
ADHD and lifestyle habits in Czech adults, a national sample
Weissenberger S, Ptacek R, Vnukova M, Raboch J, Klicperova-Baker M, Domkarova L, Goetz M
Neuropsychiatric Disease and Treatment 2018, 14:293-299
Published Date: 15 January 2018
Spotlight on once-monthly long-acting injectable aripiprazole and its potential as maintenance treatment for bipolar I disorder in adult patients
Torres-Llenza V, Lakshmin P, Lieberman DZ
Neuropsychiatric Disease and Treatment 2018, 14:285-292
Published Date: 11 January 2018
Effectiveness of high-frequency repetitive transcranial magnetic stimulation in patients with depression and Parkinson’s disease: a meta-analysis of randomized, controlled clinical trials
Qin B, Chen H, Gao W, Zhao LB, Zhao MJ, Qin HX, Yang MX
Neuropsychiatric Disease and Treatment 2018, 14:273-284
Published Date: 11 January 2018
Safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study
Katagiri H, Taketsuna M, Kondo S, Kajimoto K, Aoi E, Tanji Y
Neuropsychiatric Disease and Treatment 2018, 14:265-272
Published Date: 12 January 2018
Impact of intravenous thrombolysis on length of hospital stay in cases of acute ischemic stroke
Kasemsap N, Vorasoot N, Kongbunkiat K, Peansukwech U, Tiamkao S, Sawanyawisuth K
Neuropsychiatric Disease and Treatment 2018, 14:259-264
Published Date: 9 January 2018
Altered intrinsic brain activities in patients with acute eye pain using amplitude of low-frequency fluctuation: a resting-state fMRI study
Pan Z, Li H, Bao J, Jiang N, Yuan Q, Freeberg S, Zhu P, Ye L, Ma M, Huang X, Shao Y
Neuropsychiatric Disease and Treatment 2018, 14:251-257
Published Date: 9 January 2018
Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
Hammer-Helmich L, Haro JM, Jönsson B, Tanguy Melac A, Di Nicola S, Chollet J, Milea D, Rive B, Saragoussi D
Neuropsychiatric Disease and Treatment 2018, 14:239-249
Published Date: 9 January 2018
Anxiety and depression in paradoxical insomnia: a case–control study
Liao J, Zhu S, Li X
Neuropsychiatric Disease and Treatment 2018, 14:231-238
Published Date: 8 January 2018
Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings
Maciel A, Cullors A, Lukowiak AA, Garces J
Neuropsychiatric Disease and Treatment 2018, 14:225-230
Published Date: 8 January 2018
Efficacy and safety profile of paliperidone palmitate injections in the management of patients with schizophrenia: an evidence-based review
Emsley R, Kilian S
Neuropsychiatric Disease and Treatment 2018, 14:205-223
Published Date: 5 January 2018
Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study
Introna A, D'Errico E, Modugno B, Scarafino A, Fraddosio A, Distaso E, Tempesta I, Mastronardi A, Simone IL
Neuropsychiatric Disease and Treatment 2018, 14:193-203
Published Date: 4 January 2018
Low level of knowledge regarding diagnosis and treatment among inpatients with schizophrenia in Shanghai
Huang J, Chiovenda A, Shao Y, Ma H, Li H, Good MJDV
Neuropsychiatric Disease and Treatment 2018, 14:185-191
Published Date: 4 January 2018
Diagnostic challenges in multiple system atrophy
Obelieniene D, Bauzaite S, Kulakiene I, Keleras E, Eitmonaite I, Rastenyte D
Neuropsychiatric Disease and Treatment 2018, 14:179-184
Published Date: 4 January 2018
The current status of culturally adapted mental health interventions: a practice-focused review of meta-analyses
Rathod S, Gega L, Degnan A, Pikard J, Khan T, Husain N, Munshi T, Naeem F
Neuropsychiatric Disease and Treatment 2018, 14:165-178
Published Date: 4 January 2018
A meta-analysis of data associating DRD4 gene polymorphisms with schizophrenia
Xu F, Wu X, Zhang J, Wang B, Yao J
Neuropsychiatric Disease and Treatment 2018, 14:153-164
Published Date: 3 January 2018
The association between hippocampal subfield volumes and education in cognitively normal older adults and amnestic mild cognitive impairment patients
Kang DW, Lim HK, Joo SH, Lee NR, Lee CU
Neuropsychiatric Disease and Treatment 2018, 14:143-152
Published Date: 3 January 2018
The depressive-like behaviors of chronic unpredictable mild stress-treated mice ameliorated by Tibetan medicine Zuotai: involvement in the hypothalamic–pituitary–adrenal (HPA) axis pathway
Zhao J, Niu C, Wang J, Yang H, Du Y, Wei L, Li C
Neuropsychiatric Disease and Treatment 2018, 14:129-141
Published Date: 3 January 2018
Physical factors that influence patients’ privacy perception toward a psychiatric behavioral monitoring system: a qualitative study
Zakaria N, Ramli R
Neuropsychiatric Disease and Treatment 2018, 14:117-128
Published Date: 29 December 2017
Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
Weiller E, Weiss C, Watling CP, Edge C, Hobart M, Eriksson H, Fava M
Neuropsychiatric Disease and Treatment 2018, 14:103-115
Published Date: 29 December 2017
Receiver operating characteristic curve analysis of the Child Behavior Checklist and Teacher’s Report Form for assessing autism spectrum disorder in preschool-aged children
Bara TS, Farias AC, Felden EPG, Cordeiro ML
Neuropsychiatric Disease and Treatment 2018, 14:95-102
Published Date: 28 December 2017
Changes of serum uric acid and total bilirubin in elderly patients with major postischemic stroke depression
Gao J, Xu W, Han K, Zhu L, Gao L, Shang XL
Neuropsychiatric Disease and Treatment 2018, 14:83-93
Published Date: 27 December 2017
Quality of life and coping strategies of outpatients with a depressive disorder in maintenance therapy – a cross-sectional study
Holubova M, Prasko J, Ociskova M, Grambal A, Slepecky M, Marackova M, Kamaradova D, Zatkova M
Neuropsychiatric Disease and Treatment 2018, 14:73-82
Published Date: 22 December 2017
An acute bout of housework activities has beneficial effects on executive function
Tsuchiya K, Mitsui S, Fukuyama R, Yamaya N, Fujita T, Shimoda K, Tozato F
Neuropsychiatric Disease and Treatment 2018, 14:61-72
Published Date: 22 December 2017
Effect of rhythmic auditory cueing on gait in cerebral palsy: a systematic review and meta-analysis
Ghai S, Ghai I, Effenberg AO
Neuropsychiatric Disease and Treatment 2018, 14:43-59
Published Date: 22 December 2017
Plasma complement component 4 increases in patients with major depressive disorder
Wei J, Liu Y, Zhao L, Yang X, Ni P, Wang Y, Li T, Ma X
Neuropsychiatric Disease and Treatment 2018, 14:37-41
Published Date: 20 December 2017
The effect of demographic features on aortic arch anatomy and its role in the etiology of cerebrovascular disease
İnanç Y, İnanç Y, Ay H
Neuropsychiatric Disease and Treatment 2018, 14:29-35
Published Date: 20 December 2017
Migraine in young females with irritable bowel syndrome: still a challenge
Georgescu D, Reisz D, Gurban CV, Georgescu LA, Ionita I, Ancusa OE, Lighezan D
Neuropsychiatric Disease and Treatment 2018, 14:21-28
Published Date: 20 December 2017
Brain functional integration: an epidemiologic study on stress-producing dissociative phenomena
Sperandeo R, Monda V, Messina G, Carotenuto M, Maldonato NM, Moretto E, Leone E, De Luca V, Monda M, Messina A
Neuropsychiatric Disease and Treatment 2018, 14:11-19
Published Date: 19 December 2017
Epilepsy in patients with autism: links, risks and treatment challenges
Besag FMC
Neuropsychiatric Disease and Treatment 2018, 14:1-10
Published Date: 18 December 2017